The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127191431 12719143 1 I 201606 20160610 20160907 20160907 PER US-JNJFOC-20160611916 JANSSEN 63.03 YR A F Y 69.40000 KG 20160907 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127191431 12719143 1 PS FENTANYL TRANSDERMAL SYSTEM FENTANYL 1 Transdermal TWO PATCHES OF 12.5UG/HR N 1514689P1 19813 MATRIX PATCH
127191431 12719143 2 C OXYCODONE OXYCODONE 1 Oral EVERY 4 TO 6 HOURS 0 5 MG TABLET
127191431 12719143 3 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 0 30 MG PROLONGED-RELEASE CAPSULE QD
127191431 12719143 4 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 0 10 MG PROLONGED-RELEASE TABLET QD
127191431 12719143 5 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 1/2 10 MG 0 5 MG TABLET QD
127191431 12719143 6 C NORVASC AMLODIPINE BESYLATE 1 Oral 0 2.5 MG TABLET QD
127191431 12719143 7 C AMBIEN ZOLPIDEM TARTRATE 1 Oral 0 10 MG TABLET QD
127191431 12719143 8 C BUPROPION. BUPROPION 1 Oral 0 300 MG PROLONGED-RELEASE TABLET QD
127191431 12719143 9 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 0 4 MG TABLET
127191431 12719143 10 C TYLENOL ACETAMINOPHEN 1 Oral 0 1000 MG TABLET TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127191431 12719143 1 Pain
127191431 12719143 2 Pain
127191431 12719143 3 Attention deficit/hyperactivity disorder
127191431 12719143 4 Attention deficit/hyperactivity disorder
127191431 12719143 5 Attention deficit/hyperactivity disorder
127191431 12719143 6 Blood pressure measurement
127191431 12719143 7 Insomnia
127191431 12719143 8 Depression
127191431 12719143 9 Nausea
127191431 12719143 10 Pain

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127191431 12719143 Application site haemorrhage
127191431 12719143 Application site rash
127191431 12719143 Application site reaction
127191431 12719143 Asthenia
127191431 12719143 Feeling cold
127191431 12719143 Feeling hot
127191431 12719143 Feeling of body temperature change
127191431 12719143 Hyperhidrosis
127191431 12719143 Malaise
127191431 12719143 Nausea
127191431 12719143 Pruritus
127191431 12719143 Skin disorder
127191431 12719143 Therapeutic response decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127191431 12719143 1 201606 0
127191431 12719143 2 2014 0
127191431 12719143 3 2010 0
127191431 12719143 4 2010 0
127191431 12719143 5 2010 0
127191431 12719143 6 2015 0
127191431 12719143 7 2010 0
127191431 12719143 8 2010 0
127191431 12719143 9 2012 0
127191431 12719143 10 2001 0